The week ahead in Australian earnings The week ahead in Australian earnings The week ahead in Australian earnings

The week ahead in Australian earnings

The week ahead is a blockbuster one for earnings in Australia and with current valuations on the ASX looking stretched, upside surprises are likely to come from companies that benefit from the weaker AUD, supportive commodity prices, and US-driven growth. 

The key themes for investors to watch will be the USD earners and companies exposed to strong US growth; growth stocks with high PE ratios priced to perfection must deliver both on forward outlooks and meeting expectations, as well as capital management given Australians' love affair with dividends.

Below are some potential market movers for the week ahead.

This week Dominos reports, and despite the market expecting the firm to miss FY'18 growth targets, a miss would still be disappointing. A downgrade to FY'19 growth momentum guidance is also likely which could disappoint investors. However, Dominos does have a high level of short interest, so in the event of a positive surprise there is risk of a rally as short sellers cover their positions. 

The US has been a clear outperformer on the global macro stage in terms of growth and record low unemployment. The fiscal stimulus has the US economy running on a sugar high and this, along with the currency exposure, is likely to present positive tailwinds for Bluescope Steel next week. 

CSL is a great Australian success story, both domestically and internationally, and it reports on Wednesday, a bumper day for companies reporting. For the past two years, CSL has missed earnings expectations. CSL is trading at a price to earnings ratio of 34x forward earnings, well above comparable companies and its own historical average. With market expectations so high the onus is on CSL to deliver, and there is a risk that increased capital spending dampens FY'19 earnings guidance. While we don’t doubt that CSL is a quality Australian company with the capability to grow earnings, the high valuation does not leave any margin for safety when it comes to reporting.

Cochlear, another stock reporting this week, has also been flagged by the market as a high growth stock, with a heightened valuation. As we have seen with Facebook and Twitter suffering sharp revaluations on missed expectations, we could see sharp falls in the share price on the day if expectations are missed.  

Wesfarmers also report on super Wednesday; the Bloomberg consensus forecast for FY'18 EBIT is A$4,218, we expect the figure to come up slightly below this estimate due to falling earnings from Coles and the Industrials division of the business. 

IAG repors Wednesday as well, which is the biggest day of reporting season by market capitalisation. IAG are likely to report an upgraded FY'19 outlook due to advantageous weather conditions. This may provide an upside surprise over analyst estimates. IAG could also announce a buyback given its favourable capital position.

QBE reports on Thursday and like IAG, the reasonably stable weather conditions could reduce natural hazard losses. Given guidance is skewed to the downside, the market could take a positive report favourably


The Saxo Bank Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website. This content is not intended to and does not change or expand on the execution-only service. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (
- Full disclaimer (

40 Bank Street, 26th floor
E14 5DA
United Kingdom

Contact Saxo

Select region

United Kingdom
United Kingdom

Trade Responsibly
All trading carries risk. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more
Additional Key Information Documents are available in our trading platform.

Saxo is a registered Trading Name of Saxo Capital Markets UK Ltd (‘Saxo’). Saxo is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871. Registered in England & Wales.

This website, including the information and materials contained in it, are not directed at, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in the United States, Belgium or any other jurisdiction where such distribution, publication, availability or use would be contrary to applicable law or regulation.

It is important that you understand that with investments, your capital is at risk. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. Saxo assumes no liability for any loss sustained from trading in accordance with a recommendation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Android is a trademark of Google Inc.

©   since 1992